Breaking News

Theorem Executives to Speak at PCT

By Kristin Brooks | March 24, 2014

Will address clinical data analytics

Three executives from Theorem Clinical Research will present at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, NV, March 31 - April 2.
 
President and chief executive officer, John Potthoff, will speak on “The Real Impact of Going Public/Private on Business,” 2:00 p.m. – 3:00 p.m. on Monday, March 31. Alison Taber, vice president of global data management, will join a panel discussion on the topic of “Risk-Based Study Management for Small to Midsized Companies,” 2:30 p.m. - 3:30 p.m. on March 31. Also, Mark Penniston, executive vice president and general manager of Clinical Analytics, will discuss visual analytics and real-world applications at 4:30 p.m. on Tuesday, April 1.
           
“The amount of data collected in modern clinical trials can be completely overwhelming unless you have ways to see it that make it meaningful,” Mr. Penniston said. “Theorem has been developing advanced visual analytics tools and techniques that allow us to present complex clinical information graphically, giving you a quicker grasp and greater insight into the meaning the numbers actually represent.”

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research